Wayfinder Biosciences
PrivateLast Round
Seed
Oct 17, 2022
Total Funding Raised
$4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Wayfinder Biosciences operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Seed round in October 2022.
Wayfinder Biosciences is a biotechnology company developing a new class of orally available RNA-targeting medicines to stop disease proteins before they are made.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wayfinder Biosciences Comparables
Compare Wayfinder Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Serna Bio | 91% | |
| ReviR Therapeutics | 89% | |
| Ribometrix | 86% |
For institutional investors. Book with your work email.
Wayfinder Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 17, 2022 | ||||
| Accelerator | Jan 14, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Wayfinder Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Notation Capital | Seed |
| Notley | Seed |
| IndieBio | Seed, Accelerator |
| BoxOne Ventures | Seed |
| Conscience VC | Seed |
| Joyance Partners | Seed |
| Overlap Holdings | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 40% MoM.
- Aug 21, 2026
Monthly visitors grew 52% MoM.
For institutional investors. Book with your work email.
Wayfinder Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Wayfinder Biosciences's valuation, stock price, and market status.
Is Wayfinder Biosciences a public or private company?
Wayfinder Biosciences is a private company.
What is the current stock price of Wayfinder Biosciences?
Wayfinder Biosciences is a private company, so its shares have no public market price. Caplight tracks Wayfinder Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Wayfinder Biosciences worth (valuation)?
Valuation information for Wayfinder Biosciences is not publicly available.
Can I buy Wayfinder Biosciences stock?
Wayfinder Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Wayfinder Biosciences's last funding round?
Wayfinder Biosciences's most recent funding round was Seed on October 17, 2022.
Who are the main investors in Wayfinder Biosciences?
Key investors in Wayfinder Biosciences include Notation Capital, IndieBio, Divergent Capital.
Will Wayfinder Biosciences IPO soon?
No public IPO plans have been announced for Wayfinder Biosciences.
How can I track Wayfinder Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Wayfinder Biosciences's shares on secondary markets.